Selecta Biosciences (NASDAQ:SELB) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Selecta Biosciences beat estimated earnings by 142.86%, reporting an EPS of $0.03 versus an estimate of $-0.07.
Revenue was up $17.99 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.09 which was followed by a 3.38% drop in the share price the next day.
Here's a look at Selecta Biosciences's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.12 | -0.12 | -0.12 |
| EPS Actual | -0.16 | 0 | -0.22 | -0.14 |
| Revenue Estimate | 12.19M | 6.24M | 7.52M | 6.37M |
| Revenue Actual | 24.43M | 19.66M | 11.05M | 11.95M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
